Saturday, July 22, 2006

Doctor Indicted for Off-Label Marketing of Drug

There is always a first. So far it has been real hard for any doctor to get arrested for involvement in off-label drug use.

I wrote about this in Off-Label Prescriptions.

It was always the big drug companies paying the big fines and having their executives indicted.

But that is apparently about to change. You see some doctors may have overstepped the line and become marketers of drugs, for off-label purposes. And then, there's suddenly a different ballgame.

The following may be an extreme case, but it made the front page of New York Times.

Read all about it here.

1 comment:

Anonymous said...

Though I hate to see this kind of trouble happen to anyone, I think Dr. Gleason clearly crossed the line when he took pament for promoting off label use. Jazz Pharmaceuticals is also clearly guilty in this case.

I think that if he hadn't become a paid extension of Jazz's marketing wing, there would be no crime.